Form 4 for MD Pediatrix Medical Group, Inc.
Accepted 2024-09-03 00:00:00 ET · period of report 2024-08-30 · accession 0000950170-24-102887 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-03 | 2024-08-30 | MD | Swift James D | CEO, Dir | S - Sale | $10.79 | -11.1K | 170.0K | -6% | -$119.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-30 | S | D | 11,100 | $10.79 | 170,001 | D | — | — | (F1) The price reported in Colum 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $10.71 to $11.00 for a weighted average sales price of $10.79. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. |